Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zenke, Martin  [Clear All Filters]
2013
Weidgang CE, Russell R, Tata PR, Kühl SJ, Illing A, Müller M, Lin Q, Brunner C, Boeckers TM, Bauer K, et al. TBX3 Directs Cell-Fate Decision toward Mesendoderm. Stem Cell Reports. 2013;1(3):248-265.
Walenda G, Abnaof K, Joussen S, Meurer S, Smeets H, Rath B, Hoffmann K, Fröhlich H, Zenke M, Weiskirchen R, et al. TGF-beta1 Does Not Induce Senescence of Multipotent Mesenchymal Stromal Cells and Has Similar Effects in Early and Late Passages. PLoS One. 2013;8(10):e77656.
Willmann CA, Hemeda H, Pieper LA, Lenz M, Qin J, Joussen S, Sontag S, Wanek P, Denecke B, Schüler HM, et al. To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture. PLoS One. 2013;8(5):e65324.
2014
Qin J, Sontag S, Lin Q, Mitzka S, Leisten I, Schneider RKatharina, Wang X, Jauch A, Peitz M, Brüstle O, et al. Cell Fusion Enhances Mesendodermal Differentiation of Human Induced Pluripotent Stem Cells. Stem Cells Dev. 2014.
Wang X, Qin J, Zhao RChunhua, Zenke M. Reduced Immunogenicity of Induced Pluripotent Stem Cells Derived from Sertoli Cells. PLoS One. 2014;9(8):e106110.
2015
Lin Q, Chauvistré H, Costa IG, Gusmao EG, Mitzka S, Hänzelmann S, Baying B, Klisch T, Moriggl R, Hennuy B, et al. Epigenetic program and transcription factor circuitry of dendritic cell development. Nucleic Acids Res. 2015.
2016
Perkhofer L, Walter K, Costa IG, Carrasco MCRomero, Eiseler T, Hafner S, Genze F, Zenke M, Bergmann W, Illing A, et al. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Res. 2016;17(2):367-378.
2019
Meents JE, Bressan E, Sontag S, Foerster A, Hautvast P, Rösseler C, Hampl M, Schüler H, Goetzke R, Le TKim Chi, et al. The role of Nav1.7 in human nociceptors: insights from human iPS cell-derived sensory neurons of erythromelalgia patients. Pain. 2019.
2020
Ratnavadivel S, de Toledo MSzymanski, Rasmussen TBloch, Sarić T, Gummert J, Zenke M, Milting H. Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L. Stem Cell Res. 2020;48:101957.
2021
Boehnke J, Atakhanov S, Toledo MAS, Schüler HM, Sontag S, Chatain N, Koschmieder S, Brümmendorf TH, Kramann R, Zenke M. CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation. Stem Cell Res. 2021;55:102490.
2023
Vieri M, Tharmapalan V, Kalmer M, Baumeister J, Nikolić M, Schnitker M, Kirschner M, Flosdorf N, de Toledo MAS, Zenke M, et al. Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms. Blood Cancer J. 2023;13(1):164.
Alattar H, Xu H, Zenke M, Lutz MB. Fully functional monocytic MDSC generation from the murine HoxB8 cell line. Eur J Immunol. 2023:e2350466.
Christ A, Maas SL, Jin H, Lu C, Legein B, Wijnands E, Temmerman L, Otten J, Isaacs A, Zenke M, et al. In situ lipid-loading activates peripheral dendritic cell subsets characterized by cellular ROS accumulation but compromises their capacity to prime naïve T cells. Free Radic Biol Med. 2023.
Li Z, Kuo C-C, Ticconi F, Shaigan M, Gehrmann J, Gusmao EGade, Allhoff M, Manolov M, Zenke M, Costa IG. RGT: a toolbox for the integrative analysis of high throughput regulatory genomics data. BMC Bioinformatics. 2023;24(1):79.
Zeevaert K, Goetzke R, Mabrouk MHElsafi, Schmidt M, Maaßen C, Henneke A-C, He C, Gillner A, Zenke M, Wagner W. YAP1 is essential for self-organized differentiation of pluripotent stem cells. Biomater Adv. 2023;146:213308.